Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2010 | 07-2009 | 07-2008 | 07-2007 | |
| Sales | 4,434 | 3,841 | 3,591 | 3,424 |
| Cost of Goods | 1,669 | 1,516 | 1,239 | 1,139 |
| Gross Profit | 2,765 | 2,325 | 2,352 | 2,285 |
| Operating Expenses | 16,673 | 16,615 | 10,135 | 10,359 |
| Operating Income | -13,908 | -14,290 | -7,783 | -8,074 |
| Other Income | -515 | 206 | 972 | 505 |
| Pre-tax Income | -14,423 | -14,084 | -6,811 | -7,569 |
| Income Tax | 46 | 18 | 153 | 105 |
| Net Income Continuous | -14,469 | -14,102 | -6,964 | -7,674 |
| Net Income | $-14,469 | $-14,102 | $-6,964 | $-7,674 |
| EPS Basic Total Ops | -1.20 | -1.35 | -0.80 | -1.10 |
| EPS Basic Continuous Ops | -1.20 | -1.35 | -0.80 | -1.10 |
| EPS Diluted Total Ops | -1.20 | -1.35 | -0.80 | -1.10 |
| EPS Diluted Continuous Ops | -1.20 | -1.35 | -0.80 | -1.10 |
| EBITDA(a) | $-13,479 | $-13,906 | $-7,513 | $-6,296 |